Adjuvant FEC-D: Dose intensity and survival—What is optimal?
Zubairi, Ishtiaq Husain, Steele, Nicola, Al Zaman, Aysha, Fraser, Judith, Yule, Alison
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
RADICAL trial: A phase Ib/IIa study to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients progressing on these aromatase inhibitors (AIs)
Seckl, Michael, Badman, Philip David, Liu, Xinxue, MacPherson, Iain R., Zubairi, Ishtiaq Husain, Baird, Richard D., Garcia-Corbacho, Javier, Cresti, Nicola, Plummer, Elizabeth R., Armstrong, Anne Caroline, Allerton, Rozenn, Landers, Donal, Nicholas, Hanna, McLellan, Lyndall, Lim, Adrian K., Coombes, Charles
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors
Zubairi, Ishtiaq Husain, Dean, Emma Jane, Molife, L Rhoda, Lopez, Juanita Suzanne, Ranson, Malcolm, El-Khouly, Fatima, Savulsky, Claudio Isaac, Reyderman, Larisa, Jia, Yan, Hutton, Emily, Morrison, Rosemary, Sweeting, Lorna, Greystoke, Alastair, Barriuso, Jorge, Kristeleit, Rebecca Sophie, Evans, T.R. Jeffry
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase 1/2a trial of intravenous BAL101553, a novel tumor checkpoint controller (TCC), in advanced solid tumors
Lopez, Juanita, Evans, T.R. Jeffry, Plummer, Elizabeth R., Diamantis, Nikolaos, Shaw, Heather May, Zubairi, Ishtiaq Husain, Haris, Noor R Md, MacDonald, Julie, Greystoke, Alastair, Roux, Rene Lynnette, Tunariu, Nina, Molife, L Rhoda, Hannah, Alison L., Anderson, Stephanie, Lane, Heidi A, Maurer, Martina, Schmitt-Hoffmann, Anne, Bachmann, Felix, Engelhardt, Marc Frederick, Kristeleit, Rebecca Sophie
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A randomized Phase 2a study to assess pharmacodynamics, antitumor activity and safety of intravenous BAL101553, a novel microtubule inhibitor, at two dose levels in adult patients with selected advanced solid tumors
Kristeleit, Rebecca Sophie, Smith, Alan D., Haris, Noor R Md, Zubairi, Ishtiaq Husain, King, Judy W., de Miguel Luken, Maria Jose, D'Arcangelo, Manolo, MacDonald, Julie, Brown, Nicholas F., Calvert, Alan Hilary, Hannah, Alison L., Anderson, Stephanie, Bachmann, Felix, Maurer, Martina, Schmitt-Hoffmann, Anne, Lane, Heidi A, Engelhardt, Marc Frederick, Evans, T.R. Jeffry, Plummer, Ruth, Molife, L Rhoda
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article